Answers are grounded in this paper and cite their sources.
Omicron variant (B.1.1.529) of SARS-CoV-2 cases increased rapidly across the world.It is crucial to determine how repurposing antiviral drugs work effective to neutralizing the pathogenicity and host invading mechanism induced by SARS-CoV-2.Therefore, it is necessary to identify the active site of the omicron variant protein and its molecular interaction with selected FDA-approved drugs as well as naturally occurring bioactive compounds.This research article focused on the comparative cum holistic in silico assessment for investigating the potential inhibitory effects of bioactive compounds and repurposing drugs like lopinavir, dexamethasone, favipiravir and chloroquine against spike protein (S pro ) of omicron variant in presence of titanium dioxide nanoparticle (TiO 2 -np).The molecular docking and patch dock methods were used to explore the binding affinities of aforementioned drugs as well as compounds in presence of TiO 2 -np.This in silico study revealed, that the bioactive compounds particularly withaferin A and withanolide A derived from Withania somnifera L. showed high binding affinity -8.6 and -7.9 kcal/ mol, respectively, against the S pro of omicron variant as compared to aforementioned four FDA-approved drugs.Interestingly, the docked complex of titanium dioxide withaferin A (TiO 2 -np + withaferin A) also showed more high binding affinity against the S pro .Subsequently, the docked complex (TiO 2 -np + withaferin A) was showing as a potent inhibitor to S pro and might perform significant inhibitory effect in the invasion process of omicron variant as an antiviral agent.
No takes yet. Share an insight, caveat, or question.
Srivastava et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: